The use of drugs to enhance physical performance has occurred since the beginning of recorded time. Ancient Greeks ate mushrooms and sesame seeds to enhance performance, and Roman gladiators used stimulants to increase endurance. 1 In modern sports, documentation of the abuse of performance-enhancing drugs appeared in the early 1900s, when athletes ingested stimulants (cocaine, amphetamines, ephedrine, and strychnine) to alleviate fatigue and increase focus. 2 Anabolic-androgenic steroids (AASs) are now the most common illicit drugs used to enhance performance at the modern Olympic Games along with stimulants, primarily by weightlifters and athletes in track and field. 3 The AASs are a group of synthetic derivatives of testosterone with both skeletal muscle-building (anabolic) and masculinizing (androgenic) effects. In 1889, physiologist Charles E. Brown-Sequard reported improvement in a variety of his body functions (strength, intellect, and force of urine stream) following the injection of an extract of testicles from the dog and guinea pig. The primary natural male hormone, testosterone was first isolated from the testis of bulls in 1935 by David et al. 4 Butenandt and Hanisch 5 and Ruzicka et al. 6 independently synthesized testosterone in the same year, and both chemists received the Nobel Prize in 1939 for their work. Most of the AASs were developed during the 1950s when chemists attempted unsuccessfully to separate the anabolic and androgenic properties of these testosterone derivatives. 7 Nandrolone, the 19-nor analog of testosterone was the first anabolic steroid with sufficient dissociation of androgenic and anabolic properties to justify introduction into clinical practice during the 1950s. 8 Dr. John Ziegler, an American physician-weightlifter, administered AASs to 3 future American weightlifting champions after learning of the success of AAS-using Russian weightlifters at the 1954 World Championships. 9 In 1958, the US Food and Drug Administration (FDA) approved the use of methandrostenolone (Dianabol) for the treatment of hypogonadism, resulting in the increased availability of this steroid. By the mid-1960s, the use of AASs to Contents lists available at SciVerse ScienceDirect